⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26011205 | 1.00 | — | — | |
| SCHEMBL1086946 | 1.00 | — | — | |
| SCHEMBL26011209 | 1.00 | — | — | |
| SCHEMBL30917693 | 1.00 | — | — | |
| SCHEMBL178545 | 1.00 | — | — | |
| Bromide SCHEMBL7595850 | 0.98 | POLB (0.48) | — | |
| Iodide SCHEMBL28525835 | 0.98 | POLB (0.48) | — | |
| SCHEMBL7328192 | 0.95 | POLB (0.47) | — | |
| Lithium Ion SCHEMBL7328185 | 0.93 | POLB (0.45) | — | |
| SCHEMBL25262256 | 0.93 | CYP1A2 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1788 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4511372-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240400558-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | MIRATI THERAPEUTICS, INC | 2024-12-05 | — | — | US | claimed |
| CN-119072477-A | Process and intermediates for the synthesis of adaglazeb | 米拉蒂治疗股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-20240262866-A1 | METHOD FOR PREPARING ANIDULAFUNGIN DERIVATIVE | JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) | 2024-08-08 | — | — | US | claimed |
| EP-4398897-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-118317770-A | Process and intermediates for the synthesis of adaglazeb | 米拉蒂治疗股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-117903117-A | Preparation method of KRAS G12C inhibitor divarasib | 云南万宏医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| EP-4349851-A1 | METHOD FOR PREPARING ANIDULAFUNGIN DERIVATIVE | Shanghai Senhui Medicine Co., Ltd. (CN) | 2024-04-10 | — | — | EP | claimed |
| CN-117347527-A | Detection method of N-methyl-L-prolyl related substances | 江苏威奇达药业有限公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2023205074-A1 | PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB | Mirati Therapeutics, Inc. (US) | 2023-10-26 | — | — | WO | claimed |
| EP-2300470-A2 | IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS GABA-A RECEPTOR MODULATORS | Sepracor Inc. (US) | 2011-03-30 | — | — | EP | claimed |
| WO-2009143156-A2 | IMIDAZO[1,2-a]PYRIDINE COMPOUNDS | SEPRACOR INC. (US) | 2009-11-26 | — | — | WO | claimed |
| WO-2009030952-A2 | PHENYLCARBOXAMIDE DERIVATIVES AS INHIBITORS AND EFFECTORS OF THE HEDGEHOG PATHWAY | ASTRAZENECA AB (SE) | 2009-03-12 | — | — | WO | claimed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
| EP-0873298-A4 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMA INC (US) | 2000-05-17 | — | — | EP | claimed |
| EP-0873298-A1 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMACEUTICALS, INC. (US) | 1998-10-28 | — | — | EP | claimed |
| WO-1997011934-A1 | CHIRAL REDUCTIONS OF IMINES LEADING TO THE SYNTHESES OF OPTICALLY ACTIVE AMINES | NPS PHARMACEUTICALS, INC. (US) | 1997-04-03 | — | — | WO | claimed |
| US-4321387-A | Process for the preparation of optically active nicotine analogs | PHILIP MORRIS, INCORPORATED (US) | 1982-03-23 | — | — | US | claimed |